Status:
COMPLETED
Collagen Cross-linking in Infectious Keratitis Trial
Lead Sponsor:
Chulalongkorn University
Conditions:
Infectious Keratitis
Bacterial Keratitis
Eligibility:
All Genders
6+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.
Eligibility Criteria
Inclusion
- Evidence of corneal ulcer grade II or III (bacteria or fungal, or presumed bacterial or fungal)
- Age more than 6 year
- Patients can understand and can follow the study protocol
Exclusion
- Pregnancy by history or urine test
- Evidence of herpetic keratitis
- Evidence of corneal perforation
- Evidence of autoimmune disease
- Known allergy to study medication
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01831206
Start Date
March 1 2013
End Date
December 1 2014
Last Update
May 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology department, King Chulalongkorn Memorial hospital
Pratumwan, Bangkok, Thailand, 10330